Friendly Hills Bank Reports Fourth Quarter Results;

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
110
Friendly Hills Bank Reports Fourth Quarter Results; Announces Dan McGregor as New Chief Credit Officer

WHITTIER, Calif., Feb. 10, 2017 (GLOBE NEWSWIRE) -- Friendly Hills Bank (the “bank”) (OTCBB: FHLB ) reported results for the fourth quarter of 2016. 

For the twelve month period ending December 31, 2016, the bank reported net income of $705,000 or $0.36 per diluted share of common stock.  This figure includes a $200,000 tax benefit resulting from a reduction in the bank’s deferred tax valuation allowance and a $36,000 net gain on securities sold.  The bank reported net income of $394,000 or $0.20 per diluted share of common stock for the twelve months ended December 31, 2015.  This figure includes a $22,000 increase in the value of the interest rate caps and a $43,000 gain on other real estate owned.

As of December 31, 2016, the bank reported total assets of $143.2 million, a 14% increase from $125.6 million as of December 31, 2015.  The bank’s loan portfolio, net of unearned income, increased 10% from $67.9 million as of December 31, 2015, to $75.0 million as of December 31, 2016.  The portfolio remains diversified with $28.6 million or 38% in Commercial & Industrial Loans to local businesses (including $16.6 million in Owner Occupied Commercial Real Estate Loans), $18.2 million or 24% in Residential Real Estate Loans to investors and $23.1 million or 31% in Commercial Real Estate Loans to investors.  The bank has an additional $22.8 million in unfunded loan commitments.

The bank’s overall deposit base has increased 19% in the twelve months ended December 31, 2016, from $96.9 million as of December 31, 2015, to $115.5 million as of December 31, 2016.  Non-interest bearing deposits continue to form a substantial part of the deposit base (41%), growing from $42.5 million to $47.5 million as of December 31, 2016.  During the same time period interest-bearing deposits increased from $54.4 million to $68.0 million on December 31, 2016.  The bank has no deposits which were sourced through brokers or other wholesale funding sources. 

At December 31, 2016, shareholders’ equity was $15.9 million and the bank’s total risk-based capital ratio was 17%, significantly exceeding the “well-capitalized” level of 10% prescribed under regulatory requirements. The bank also continues to maintain substantial liquidity positions, retaining significant balances of liquidity as well as available collateralized borrowings and other potential sources of liquidity.

“The bank had a very strong quarter in terms of growth which is attributable to improving economic conditions in our local markets,” commented Jeffrey K. Ball, Chief Executive Officer. “Most importantly we have been able to achieve this growth while maintaining a strong balance sheet with consistent underwriting standards and continued diversification of our loan portfolio. Our deposit base continues to be focused on core deposits which tend to have higher volatility but also provide a low cost funding source which we feel will continue to benefit the bank in a rising interest rate environment. To help us effectively manage this growth we are pleased to welcome Dan McGregor to our team as an Executive Vice President and Chief Credit Officer. Having worked over 30 years in the banking industry he brings tremendous experience in credit management and community banking which will be valuable as we continue to selectively grow the bank.”

Company Profile: Friendly Hills Bank is a community bank which was formed to primarily serve the Southern California communities of eastern Los Angeles County and northern Orange County.  The bank was established in 2006 by prominent members of the local community who were seeking an alternative to the larger financial institutions in the area.  The bank is headquartered in Whittier, California with an additional branch office in Santa Fe Springs, California.  For more information on the bank, please visit www.friendlyhillsbank.com or call 562-947-1920.

Forward Looking Statements: The numbers in this press release are unaudited. Statements such as those regarding the anticipated development and expansion of Friendly Hills Bank's business, and the intent, belief or current expectations of the bank, its directors or its officers, are "forward looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking statements. These risks and uncertainties include, but are not limited to, risks related to the local and national economy, the bank's performance, including its ability to generate loan and deposit growth, changes in interest rates, and regulatory matters.

Friendly Hills Bank
Balance Sheets (Unaudited)
(in thousands, except per share information)
             
      12/31/16   12/31/15  
ASSETS          
Cash and due from banks $ 4,747     $ 3,904    
Interest bearing deposits with other financial institutions   14,818       4,529    
    Cash and Cash Equivalents   19,565       8,433    
Investment securities available-for-sale   42,183       43,312    
Federal Home Loan Bank stock Federal Reserve Bank stock   779 474       753 455    
Loans, net of unearned income   74,986       67,876    
Allowance for loan losses   (1,525 )     (1,595 )  
    Net Loans   73,461       66,281    
Premises and equipment, net   244       211    
Accrued interest receivable and other assets   6,461       6,134    
    Total Assets $ 143,167     $ 125,579    
             
LIABILITIES AND SHAREHOLDERS’ EQUITY        
Liabilities          
Deposits          
  Noninterest-bearing deposits $ 47,517     $ 42,531    
  Interest-bearing deposits   68,012       54,354    
    Total Deposits   115,529       96,885    
FHLB advances   11,000       13,000    
Accrued interest payable and other liabilities   772       452    
    Total Liabilities   127,301       110,337    
Shareholders’ Equity        
  Common stock, no par value, 10,000,000 shares authorized:        
  1,939,200 shares issued and outstanding   15,958       15,958    
  Additional paid-in-capital   1,091       1,091    
  Accumulated deficit   (946 )     (1,651 )  
  Accumulated other comprehensive income (loss)   (237 )     (156 )  
    Total Shareholders’ Equity   15,866       15,242    
    Total Liabilities and Shareholders’ Equity $ 143,167     $ 125,579    
             
Book Value Per Share $ 8.18     $ 7.86    
Friendly Hills Bank
Statements of Operations (Unaudited)
(in thousands, except per share information)
           
      For the twelve   For the twelve
      months ended   months ended
      12/31/16   12/31/15
Interest Income $ 4,577     $ 4,396  
Interest Expense   318       305  
  Net Interest Income   4,259       4,091  
Provision for Loan Losses   0       0  
  Net Interest Income after Provision for Loan Losses   4,259       4,091  
Noninterest Income   447       459  
Noninterest Expense   3,931       3,998  
Non-Recurring Items   35       67  
Income before Provision for Income Taxes   810       619  
(Provision) Benefit for Income Taxes   (105 )     (225 )
  Net Income $ 705     $ 394  
           
Basic and Diluted Earnings Per Share $ 0.36     $ 0.20  

Contacts: Jeffrey K. Ball (President & CEO) Daniel L. Erickson (EVP & CFO) (562) 947-1920

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading